Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement Insights from in vivo imaging by Serrels, Alan et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Src/FAK-mediated regulation of E-cadherin as a mechanism for
controlling collective cell movement Insights from in vivo
imaging
Citation for published version:
Serrels, A, Canel, M, Brunton, VG & Frame, MC 2011, 'Src/FAK-mediated regulation of E-cadherin as a
mechanism for controlling collective cell movement Insights from in vivo imaging' Cell adhesion & migration,
vol 5, no. 4, pp. 360-365. DOI: 10.4161/cam.5.4.17290
Digital Object Identifier (DOI):
10.4161/cam.5.4.17290
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Cell adhesion & migration
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
 Special FocuS Review: Recent advanceS in cell-cell adheSion
cell adhesion & Migration 5:4, 360-365; July/august 2011; © 2011 landes Bioscience
360 cell adhesion & Migration volume 5 issue 4
Introduction
The ability of cells to invade and metastasize is linked to de-
regulation of interactions with adjacent cells and surrounding 
extracellular matrix (ECM). The de-stabilization of cell-cell 
contacts and concomitant ‘enrichment’ of integrin-mediated 
cell-matrix adhesions is likely a key step in the development of 
cancer, and is linked to epithelial plasticity and the Epithelial to 
Mesenchymal Transition (EMT). The adhesion switch is often 
accompanied by an increase in the migratory potential of tumor 
cells, and may play a key role in driving tumor cell invasion.1 
However, EMT is not necessarily a pre-requisite for tumor cell 
invasion. Normal cells can move in a collective manner that is 
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Recent advances in confocal and multi-photon microscopy, 
together with fluorescent probe development, have enabled 
cancer biology studies to go beyond the culture dish and 
interrogate cancer-associated processes in the complex in 
vivo environment. Regulation of the tumor suppressor protein 
e-cadherin plays an important role in cancer development 
and progression, and may contribute to the decision between 
‘single cell’ and ‘collective invasion’ in vivo. Mounting evidence 
from in vitro and in vivo experiments places the two non-
receptor protein tyrosine kinases Src and Focal adhesion 
Kinase at the heart of e-cadherin regulation and the crosstalk 
between integrins and cadherins. here we discuss recent 
insights, attained using high-resolution fluorescent in vivo 
imaging, into the regulation of e-cadherin and collective 
invasion. we focus on the regulatory crosstalk between the 
Src/FaK signaling axis and e-cadherin in vivo.
Src/FAK-mediated regulation of E-cadherin  
as a mechanism for controlling  
collective cell movement
Insights from in vivo imaging
alan Serrels,* Marta canel, valerie G. Brunton and Margaret c. Frame
edinburgh cancer Research uK centre; institute of Genetics and Molecular Medicine; university of edinburgh; edinburgh, uK
Key words: Src, FAK, E-cadherin, EMT, fluorescent in vivo imaging
Abbreviations: ECM, extracellular matrix; EMT, epithelial to mesenchymal transition; FAK, focal adhesion kinase; AJs, 
adherens junctions; TGFβ, transforming growth factor beta; GFP, green fluorescent protein; FRAP, fluorescent recovery after 
photobleaching
dependent on the maintenance of cell-cell adhesion,2 as occurs 
in the well characterized phenomenon of collective cell move-
ment in morphogenesis.3 Understanding how de-regulation of 
cell-cell contact occurs, and the mechanisms that regulate col-
lective cell movement during tumor development are important 
current topics in cancer research, and may lead to new anti- 
invasive strategies. Recent technological advances in the appli-
cation of high-resolution fluorescent microscopy in vivo has 
enabled researchers to probe these processes in greater detail, 
thereby providing insights into the pathways that regulate 
E-cadherin, cell-cell adhesion and collective cell movement in 
pre-clinical cancer models. Here we review how confocal and 
multi-photon microscopy have added to the study of E-cadherin 
and collective cell invasion in vivo, including studies on regula-
tion involving Src/Focal Adhesion Kinase (FAK) signaling.
E-Cadherin and Cancer
E-cadherin is the prototypical member of the type-1 classical 
cadherins and a key component of cell-cell adhesions known 
as adherens junctions (AJs). This single-pass transmembrane 
glycoprotein facilitates cell-cell adhesion via a homophilic cal-
cium-dependent interaction with opposing molecules on neigh-
boring cells4 and is commonly de-regulated in many cancers.5 
E-cadherin expression or cell surface localization is often lost in 
advanced tumors5 and this loss is linked, at least in some cases, to 
metastasis and tumor recurrence.6 Loss of E-cadherin in human 
tumors is often the result of promoter methylation or upregula-
tion of the transcriptional repressors Snail, Slug, SIP1 or Zeb1, 
which target the E-cadherin promoter.7 However, de-regulation 
of E-cadherin surface localization has also been linked to the 
activity of non-receptor tyrosine kinases that have oncogenic 
potential, including Src and FAK,8,9 or the action of transform-
ing growth factor beta (TGFβ),10 and hepatocyte growth factor 
(HGF).11
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although mechanisms are not yet fully understood. The culture 
dish represents a very simplistic system for studying biology and 
there is a drive to move toward more physiological environments. 
The field of high-resolution fluorescent intra-vital microscopy 
affords us this opportunity and has enabled researchers to study 
complex biological problems in a setting that is more physiologi-
cally relevant.
High Resolution Cancer Imaging in Mice
Recent advances in confocal and multi-photon microscopy, 
together with the development of fluorescent probes, have led to 
new cancer biology studies in vivo. These techniques show great 
promise in furthering our understanding of tumor/host interac-
tions in the in vivo environment, and the mode of action of novel 
therapeutic agents. For example, using multi-photon micros-
copy the Condeelis lab have identified an intimate relationship 
between tumor cells and infiltrating macrophages, providing 
support for a role for macrophages in aiding tumor cell inva-
sion and entry into blood vessels.24 Fluorescent labeling of tumor 
cells with Green Fluorescent Protein (GFP), and its variants, has 
enabled visualization of single tumor cells either via exterioriza-
tion of the primary tumor (subcutaneous, orthotopic or geneti-
cally engineered tumor models) or through the establishment of 
tumors under ‘optical windows.’ These windows act to replace 
the mouse skin, which represents an impenetrable barrier that 
does not permit confocal and multi-photon microscopy due to 
contrast-robbing autofluorescence and excessive light scattering. 
A glass coverslip or ‘optical window’ provides a suitable transpar-
ent surface through which to image the tumor sample. Recently, 
different optical window types have been described, including 
the dorsal skinfold window (Fig. 1A),21,25,26 the mammary win-
dow (Fig. 1B),27 and the cranial window (similar design to mam-
mary window).26
Aside from optical performance, these windows provide a 
number of other benefits. First, using anesthetics such as isoflu-
orane, repeated imaging can be performed on a routine basis, 
thus facilitating the observation of tumor-associated processes 
over periods of days or weeks. Second, no surgery is required 
at the time of imaging, thereby minimising the risk of an arti-
factual inflammatory response that may affect tumor behavior. 
Third, mechanical clamping of the window to the microscope 
stage greatly reduces sample movement, thereby facilitating 
the application of advanced imaging techniques that include 
Fluorescence Recovery After Photobleaching (FRAP) and photo-
activation to enable molecular dynamic studies deep in tumor tis-
sue. However, optical windows also have their limitations. These 
include cell/tissue adhesion to the glass coverslip (although this 
can be overcome by careful replacement of the coverslip) and 
the time-consuming surgical installation of the windows, which 
takes longer than surgical exteriorisation of tumors for imag-
ing. Both approaches have been used for imaging cell behavior 
and the surrounding microenvironment in tumor-bearing mice, 
providing new insights into, among other things, the regulation 
of E-cadherin dynamics, cell-cell adhesion and collective cell 
migration in vivo.
Src/FAK Regulation of E-Cadherin
Src is the prototypical member of the Src family of non-receptor 
tyrosine kinases and complexes with FAK at sites of cell-matrix 
adhesion often termed focal adhesions or focal contacts. Elevated 
expression of these kinases has been reported in many tumor 
types, and is frequently linked to poor clinical outcome.12-20 
Several lines of evidence now support the idea of crosstalk 
between components of integrin adhesions and AJs, and sug-
gest that Src/FAK signaling is at the heart of this crosstalk. For 
example, Src induced de-regulation of E-cadherin in colon cancer 
cells is dependent on integrin signaling and FAK phosphoryla-
tion.9 In support of this, treatment of hepatocytes with the Src 
inhibitor PP2, or expression of the endogenous interfering version 
of FAK, namely FAK-related non-kinase (FRNK), is reported to 
inhibit TGFβ-induced de-localization of E-cadherin.10 Taken 
together, these data suggest that status of the Src/FAK signaling 
axis controls epithelial morphology, including TGFβ-induced de-
regulation of E-cadherin. Recently, we have shown that siRNA 
mediated depletion of FAK or β1-integrin, and inhibition of Src 
family kinase activity using the small molecule inhibitor dasat-
inib, causes inhibition of E-cadherin endocytosis, phenocopying 
effects of the dynamin inhibitor dynasore.21 Furthermore, inhibi-
tion of the Src/FAK pathway using dasatinib and PF-562,271, 
or downregulation of FAK expression using siRNA, strengthens 
E-cadherin-mediated cell-cell adhesions, while overexpression of 
a Src Y527F mutant with constitutive kinase activity results in 
weakening of cell-cell adhesion strength. Using the human A431 
squamous carcinoma cell line, which invades in a collective man-
ner that is dependent on AJs integrity,22 Src/FAK-mediated effects 
on E-cadherin and cell-cell adhesion strength were observed to 
correlate with altered E-cadherin dynamics at sites of cell-cell 
adhesion and inhibition of collective tumor cell invasion in vitro.21 
These data provide strong evidence that Src/FAK signaling regu-
lates E-cadherin membrane localization and function, such that 
increased pathway activity de-regulates E-cadherin and drives 
EMT, while reduced pathway activity maintains E-cadherin 
membrane localization and epithelial morphology.
What is not clear is the role of Src/FAK signaling in the for-
mation of new cell-cell adhesions. Overexpression of the gain-of-
function Src Y527F mutant inhibits new junction formation in a 
manner that depends on FAK phosphorylation by Src.9 This sta-
bilizes the mesenchymal-like phenotype resulting from SrcY527F 
expression in colon carcinoma cells. However, in NBT-II rat 
bladder carcinoma cells, expression of a kinase defective FAK 
mutant inhibits the formation of new E-cadherin-mediated cell-
cell adhesions, while overexpression of FAK itself has no effect on 
junction assembly.23 These somewhat paradoxical results leave an 
unclear picture as to the role of Src/FAK signaling in the forma-
tion of new cell-cell adhesions, suggesting that further work is 
required in order to fully understand the complexity, and pos-
sibly context dependence, of AJ assembly.
In vitro studies addressing the role of Src/FAK signaling in 
the regulation of E-cadherin, cell-cell adhesion and collective 
cell migration have provided insights into the crosstalk between 
key components of integrin-based cell-matrix adhesions and AJs, 
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Further insights into the mechanisms regulating E-cadherin 
and cell-cell adhesion integrity in vivo comes from our recent 
work addressing the role of Src/FAK signaling in the regulation 
of E-cadherin, cell-cell adhesion and collective cell migration. 
We established the existence of extensive regulatory cross-talk 
between components of integrin-based cell-matrix adhesions and 
AJs in the in vivo environment, particularly E-cadherin mem-
brane dynamics, cell-cell adhesion integrity and collective cell 
migration within primary tumors. We discuss this work below, 
introducing some principles for imaging of E-cadherin dynamics 
and cell tracking in an in vivo tumor context.
We first performed high-resolution confocal microscopy, 
focusing on the comparison of E-cadherin membrane dynam-
ics between in vitro confluent cell monolayers and subcutaneous 
epithelial tumors established following injection of human A431 
epidermoid squamous carcinoma cells that had been engineered 
ex vivo to express GFP-tagged E-cadherin. Using FRAP, we 
identified a molecular dynamic signature in vitro based on recov-
ery half-time and immobile fraction measurements that corre-
lates with the migratory capacity of cells. The rate of fluorescent 
recovery provides a measure of how quickly mobile molecules 
move into the bleached region and specifies a parameter known 
as the recovery half-time. This is determined by the way in 
which molecules move within the cell, i.e., whether they undergo 
simple diffusion, vesicle trafficking, or binding interactions 
with other molecules in the local environment.31 Studies using 
GFP-E-cadherin or a photoactivatable form of GFP-E-cadherin, 
together with inhibitors of endocytosis, i.e., dynasore, suggest 
that half-time measurements are likely a readout of E-cadherin 
endocytosis, lateral movement within the plasma membrane or 
a combination of both.32,33 However, the relative contribution of 
each is somewhat context-dependent. The cellular environment 
Imaging Collective Tumor Cell Movement
The ability of tumor cells to migrate as strands or sheets in a collec-
tive manner has been reported following implantation of human 
tumor samples into 3D collagen lattices.28 These experiments iden-
tify multi-cellular clusters of various sizes, which actively migrate 
from tissue into the surrounding collagen, suggesting that tumor 
cells can migrate while maintaining cell-to-cell contact. Indeed, 
the maintenance of functional cell-cell adhesions, and therefore 
physical contact with neighboring cells, is a hallmark of so called 
collective invasion.29 The first demonstration of tumor cell col-
lective invasion in vivo was recently reported by the Friedl lab.25 
These authors combined high-resolution multi-photon imaging 
with dorsal skin-fold windows, and identified both individually 
migrating cells, and two morphologically distinct patterns of col-
lective invasion following injection of HT-1080 fibrosarcoma cells 
deep into the mouse dermis.25 The authors also reported a role 
for surrounding tissue architecture as a determinant of the choice 
between singe cell invasive migration and collective invasion. Real-
time imaging of MTLn3E breast tumors in vivo by the Sahai lab, 
has also shown the presence of both collective and singly migrat-
ing cells. Moreover, use of fluorescent reporters of TGFβ activity, 
such as GFP-Smad2 and CAGA
12
-CFP, has demonstrated that the 
decision to move as a single cell or in a collective manner can be 
driven by localized TGFβ activation, resulting in a transient and 
reversible EMT.30 Together, these studies indicate the presence of 
multiple factors within the tumor microenvironment that influ-
ence the mode of tumor cell invasion in vivo. Furthermore, the 
presence of both single and collectively invading cells within indi-
vidual tumors, and the possibility of plasticity i.e., inter-conversion 
between these, suggests that de-regulation of E-cadherin and cell-
cell adhesions may be a key determinant of invasion mode.
Figure 1. images of optical window chambers. (a) tagRFp-expressing tumor under dorsal skinfold window (red), with GFp autofluorescence image 
(green) and brightfield overlay (gray). cropped image acquired using 0.14x objective lens on olympus ov110 microscope. (B) Mda-MB-231 GFp ex-
pressing tumor under mammary window (green) with brightfield overlay (gray) acquired using 0.14x objective lens on olympus ov110 microscope.
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optical windows. Treatment of tumors with PF-562,271 resulted 
in a shorter recovery half-time and no change in immobile frac-
tion, mimicking the effects of PF-562,271 treatment in cells in 
culture. Further investigation in vitro revealed that these dynamic 
changes in E-cadherin mobility at sites of cell-cell adhesion cor-
relate with inhibition of E-cadherin endocytosis, inhibition of 
collective invasion into a 3D collagen matrix and strengthening 
of cell-cell adhesion. In addition, these studies confirm that GFP-
E-cadherin recovery half-time measurements are at least in part 
a measure of the rate of E-cadherin endocytosis.21 These imaging 
studies provide new insights into the existence of regulatory cross-
talk between components of integrin-based cell-matrix adhesions 
and AJs in vivo, while further identifying potential mechanisms 
underlying the potential anti-invasive effects of small molecule 
tyrosine kinase inhibitors targeting Src/FAK signaling in epithe-
lial tumors. However, these studies do not rule out the possibility 
that inhibition of Src/FAK signaling may have a general effect 
on cell motility, independent of E-cadherin and AJs status, that 
may contribute to the potential anti-invasive effects of Src/FAK 
inhibition in epithelial tissue.
Conclusions and Future Perspectives
To date very few studies have investigated the role of Src/FAK 
signaling in the cancer-associated regulation of E-cadherin and 
cell-cell adhesion by imaging in the in vivo setting. In vitro cell 
culture can at best only partially re-capitulate the in vivo envi-
ronment; new techniques allow this to be overcome with the use 
of high-resolution imaging in vivo. Indeed, in vivo confocal and 
multi-photon microscopy has highlighted the heterogeneity of 
tumor cell invasion modes, even within individual tumors,25,30 
and indicated that localized signaling gradients in primary 
tumors can induce transient and reversible EMT.30 Such insights 
could not have been gained from purely in vitro studies. Evidence 
emerging from our own in vivo studies investigating the role of 
Src/FAK signaling in E-cadherin and cell-cell adhesion regula-
tion implies that inhibition of this signaling pathway strength-
ens cell-cell adhesion in vivo,21 promoting a more epithelial-like 
morphology and suppressing epithelial tumor cell migration. 
As expected, the biology in vivo is complex and we hypothesize 
that inhibition of Src/FAK signaling may counteract the pro-
EMT signals within the tumor microenvironment, such as those 
induced by TGFβ, therefore reducing the movement within and 
away from the tumor. Studies addressing the mechanisms that 
underpin tumor cell responses to small molecule inhibitors in 
vivo are therefore important in testing putative anti-cancer thera-
pies. High-resolution in vivo imaging in the pre-clinical setting 
will aid understanding of tumor/host interplay and predicting 
responses to therapeutic intervention. New quantitative probes 
for cancer biology imaging in vivo, particularly if these can be 
applied to more relevant cancer models (genetically engineered), 
will facilitate further progress.
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also imposes further restrictions on mobility, such that some mol-
ecules are detained and therefore do not vacate physical space 
required for new unbleached molecules to occupy. Such a situ-
ation gives rise to an incomplete recovery when compared with 
the initial fluorescent signal and when measured is termed the 
immobile fraction.31 We concluded that non-motile cells exhibit 
a faster recovery half-time and a higher immobile fraction. 
Comparison of E-cadherin dynamics at sites of cell-cell adhesion 
between cell cultures in vitro and tumors in vivo identified sig-
nificant differences between these environments, both in terms 
of basal dynamics and response to therapeutic treatment with the 
Src kinase inhibitor dasatinib. Treatment of tumor-bearing mice 
with dasatinib alters E-cadherin dynamics in a manner indica-
tive of reduced migratory capacity,34 although quantitative mea-
surement of the true migratory behavior of these cells was not 
determined. Surgical exposure of the tumor as a skin-flap in these 
experiments restricted the quantification of migratory behavior, 
and also provided challenges in terms of minimising focal drift 
of the sample in the x, y and z axis required for techniques such 
as FRAP and photoactivation.
Switching of our experimental approach from skin-flaps 
to dorsal skin-fold windows greatly reduced sample movement 
during image acquisition, at the same time allowing us to use 
recoverable anesthesia to perform long-term tracking of tumor 
cell behavior over multiple imaging sessions.21 Similar approaches 
have been described elsewhere in references 25–27. When cou-
pled with photoswitchable fluorescent proteins, this provides a 
means of tracking sub-populations of tumor cells over a period 
of 24–48 h.21,27 Quantitative measurement of A431 collective 
cell migration in vivo using this approach revealed that inhibi-
tion of either FAK or Src kinase activity (using the kinase inhibi-
tors PF-562,271 and dasatinib respectively), results in inhibition 
of cell migration within the primary tumor (Fig. 2A),21 thereby 
targeting a process that is likely to be required for the intra-vasa-
tion and dissemination of tumor cells from the primary tumor. 
Moreover, identification of multi-cellular strands some distance 
from the original activation point suggested the presence of col-
lectively migrating cells within these tumors (Fig. 2B), although 
this cannot be definitively proved using an assay based on the 
acquisition of still images at any given time. While individual 
labeled cells are also visible, we cannot tell whether these were sin-
gly migrating cells or cells migrating in a collective manner with 
cells that had not been switched from green to red. This assay 
format does not permit the accurate quantification of singly and 
collectively migrating cells, but it does allow quantification and 
visualization of what appears to be collective migration. The pho-
toswitching of Dendra2-labeled tumor cells through mammary 
windows has also been used for measurement of tumor cell entry 
into blood vessels, with the sub-population of cells being selected 
for their proximity to a blood vessel.27 This approach established 
that Src/FAK signaling is required for the collective migration of 
tumor cells in vivo, and also provided pre-clinical evidence that 
dasatinib and PF-562,271 display anti-invasive effects (Fig. 2A).21
To investigate the mechanism by which Src/FAK signaling 
was regulating collective cell migration in vivo, we used FRAP 
in GFP-tagged E-cadherin-expressing tumor cells grown under 
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Figure 2. visualizing collective cell migration in living animals. (a) confocal images showing a431 dendra2 cells in tumors of untreated mice or mice 
treated with pF-562,271 or dasatinib, at different time points after photoswitching (red). Scale bars, 100 μm. (B) Zoomed images from a control tumor 
(left) and higher magnification images (center and right) showing collective cell movement. *individual cells within a group; scale bars, 20 μm (left and 
center images) and 10 μm (right image). all images presented in this figure have been previously published in reference 21.
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